Welcome to our dedicated page for Mobix Labs SEC filings (Ticker: MOBX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking Mobix Labs’ progress means wading through pages packed with RF engineering talk, defense export rules, and supply-chain diagrams. If finding R&D spend or a design-win update in the latest 10-K feels daunting, you’re not alone.
Stock Titan solves that problem. Our AI reads every Mobix Labs annual report 10-K simplified, Mobix Labs quarterly earnings report 10-Q filing, and Mobix Labs 8-K material events explained the moment they hit EDGAR. It extracts what professionals actually need—chip sales by end-market, defense-contract exposure, pending patents—then writes a plain-English brief you can absorb in minutes. Want to follow Mobix Labs insider trading Form 4 transactions? Real-time alerts show executive stock moves before markets react, so you can monitor Mobix Labs executive stock transactions Form 4 without refreshing a spreadsheet.
Here’s what you’ll uncover on this page:
- 10-K & 10-Q—AI breakdowns of revenue by automotive, medical, and aerospace customers, plus year-over-year R&D trends.
- 8-K—Instant summaries whenever design-wins, supply-chain disruptions or leadership changes surface.
- Form 4—Mobix Labs Form 4 insider transactions real-time, helping you track buying before new product announcements.
- DEF 14A proxy statement executive compensation analysis outlining option grants tied to RF innovation milestones.
Whether you’re comparing quarter-over-quarter gross margin shifts or simply understanding Mobix Labs SEC documents with AI, every filing is here, already explained, and continuously updated. Save hours, gain clarity, and make informed decisions with data that matters.
Mobix Labs, Inc. (MOBX) reported an amended insider filing (Form 4/A) to correct the officer’s reported holdings. The amendment updates the directly held Class A common stock beneficially owned to 2,550,000 shares as of the prior filing date referenced.
The filing also lists indirect derivative holdings through the KSSF Trust tied to 125,000 shares of Class A. The Class B common stock is convertible into Class A at the holder’s option and will convert automatically upon a non‑permitted transfer or on the first trading day after the seventh anniversary of the December 21, 2023 closing date. The reporting person serves as President, CFO & Director.
Mobix Labs, Inc. (MOBX) insider filing: The Chief Executive Officer and Director reported an award of 1,000,000 Restricted Stock Units on September 19, 2025 at a price of $0.00. The RSUs are scheduled to vest in four equal 25% installments on January 1, 2027, April 1, 2027, July 1, 2027, and October 1, 2027. After this grant, the reporting person beneficially owns 2,035,885 shares of Class A common stock, held directly.
Mobix Labs, Inc. (MOBX) filed an amended Form S-1 registering the resale of up to 12,890,274 shares of Class A common stock by selling stockholders. The company is not selling any shares in this offering and will not receive proceeds from stockholder sales.
If outstanding warrants covered by this prospectus are exercised for cash, Mobix Labs states it would receive approximately $9.8 million in gross proceeds. The filing notes the registered shares would equal about 18% of outstanding Class A shares as of September 4, 2025, and that resales—or the perception of them—could pressure the trading price.
The prospectus also highlights recent financing activities. On September 3, 2025, a holder exercised 5,486,467 warrants for cash at $0.8202 per share, generating ~$4.5 million in gross proceeds, and received new inducement warrants for 8,229,701 shares at $1.08. On August 13, 2025, the company issued a $550,000 senior secured note convertible at $0.70 (up to 2,500,000 shares), with 150,000 commitment shares and caps including a 4.99% beneficial ownership limit and an exchange cap of 5,747,105 shares.
Bill Carpou, a director of MOBIX LABS, INC. (MOBX), reported equity changes dated 09/23/2025. The filing shows a grant of 46,855 Restricted Stock Units (RSUs) to the reporting person, increasing his direct beneficial ownership to 299,022 Class A common shares after the transaction. The report also discloses two fully vested stock options: one with an exercise price of $4.18 covering 20,000 shares (expiring 08/10/2030) and another with an exercise price of $6.84 covering 133,416 shares (expiring 04/04/2032). The form was signed on behalf of the reporting person by an attorney-in-fact on 09/25/2025.
Frederick C. Goerner, a director of Mobix Labs, Inc. (MOBX), reported multiple equity awards and holdings. On 09/23/2025 he was granted 46,855 Restricted Stock Units (RSUs) with a reported price of $0, bringing his reported beneficial ownership to 1,483,380 shares of Class A Common Stock (direct). The filing also shows fully vested, exercisable options to purchase 20,000 shares at $4.18 and 133,416 shares at $6.84. Additionally, the report lists 217,391 shares of Class B Common Stock convertible into Class A Common Stock; conversion occurs at the Reporting Person's option and will be automatic upon certain transfers or upon the first trading day after the seventh anniversary of the Closing Date. The Form 4 was signed by an attorney-in-fact on 09/25/2025.
Kurt Busch, a director of Mobix Labs, Inc. (MOBX), reported awards and existing holdings on a Form 4 dated with transactions on 09/23/2025. The filing shows 46,855 restricted stock units (RSUs) were granted to Mr. Busch on 09/23/2025, increasing his beneficial ownership to 372,429 shares of Class A common stock.
The report also lists two fully vested, exercisable stock options held directly by Mr. Busch: an option to buy 20,000 shares at an exercise price of $4.18 (expiration 08/10/2030) and an option to buy 133,416 shares at $6.84 (expiration 04/04/2032). The Form 4 was signed by an attorney-in-fact, Terri Aprati, on 09/25/2025.
Mobix Labs insider report: Director David J. Aldrich received 46,855 Restricted Stock Units on September 23, 2025 that will vest on October 1, 2025, and acquired the RSUs at no cash cost. Following that grant, he beneficially owns 289,744 shares of Class A common stock.
Derivative holdings: The filing discloses two fully vested, exercisable stock options: 20,000 options with a $4.18 exercise price (expiring 08/10/2030) and 133,416 options with a $6.84 exercise price (expiring 04/04/2032). The form was signed by an attorney-in-fact on September 25, 2025.
Mobix Labs insider ownership and awards disclosed in Schedule 13D. Keyvan Samini and related trusts report beneficial ownership of 3,316,733 shares of Class A common stock (including 125,000 Class B shares convertible into Class A), representing 5.6% of voting power based on the stated share counts. The filing describes acquisition of Class A shares, options and a grant of 2,550,000 restricted stock awards to Samini on May 5, 2025, which vest over two years and may accelerate at certain stock-price thresholds. Samini is President, CFO and a director of the issuer; employment agreements and multiple equity awards and RSUs are summarized and incorporated by reference.
MOBIX LABS, INC. director Bill Carpou reported a sale of 19,953 shares of Class A common stock on 09/12/2025 at an average price of approximately $0.9418 per share, reducing his direct holdings to 252,167 shares. The filing also shows two fully vested options: one exercisable at $4.18 per share covering 20,000 underlying shares (expires 08/10/2030) and another at $6.84 covering 133,416 shares (expires 04/04/2032). The report was signed by an attorney-in-fact on 09/16/2025 and includes an explanation that sale prices ranged from $0.9418 to $0.9419 and that option grants are fully vested and exercisable.
MOBIX Labs, Inc. (MOBX) filed an S-1 that discloses its post-merger financial position, material financing transactions and near-term liquidity risk. The company completed a business combination and began trading on Nasdaq under MOBX and MOBXW, received a $19,750 PIPE at $10.00 per share and raised net proceeds of $3,645 in an April 2025 offering. For the nine months ended June 30, 2025 the condensed statements show a net loss of $30,402 and an accumulated deficit of $134,859. Management states there is substantial doubt about going concern, citing inadequate liquidity beyond ~ninety days and the need for additional debt or equity financing.
FAQ
What is the current stock price of Mobix Labs (MOBX)?
What is the market cap of Mobix Labs (MOBX)?
